Bachovchin, Daniel A
Koblan, Luke W
Wu, Wengen
Liu, Yuxin
Li, Youhua
Zhao, Peng
Woznica, Iwona
Shu, Ying
Lai, Jack H
Poplawski, Sarah E
Kiritsy, Christopher P
Healey, Sarah E
DiMare, Matthew
Sanford, David G
Munford, Robert S
Bachovchin, William W
Golub, Todd R
Article History
Received: 13 January 2013
Accepted: 29 May 2014
First Online: 6 July 2014
Competing interests
: W.B.W. is a co-founder, advisor and board member of Arisaph Pharmaceuticals, a biotechnology company interested in developing boronic acid-based inhibitors of serine hydrolases as therapeutics. C.K. is a co-founder, CEO and board member of Arisaph Pharmaceuticals.
Free to read: This content has been made available to all.